{"id":"https://openalex.org/W4289080147","doi":"https://doi.org/10.1016/j.omtm.2022.07.014","title":"Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene","display_name":"Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene","publication_year":2022,"publication_date":"2022-07-31","ids":{"openalex":"https://openalex.org/W4289080147","doi":"https://doi.org/10.1016/j.omtm.2022.07.014","pmid":"https://pubmed.ncbi.nlm.nih.gov/36092362","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9437807"},"language":"en","primary_location":{"id":"doi:10.1016/j.omtm.2022.07.014","doi":"https://doi.org/10.1016/j.omtm.2022.07.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2022.07.014","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Methods & Clinical Development","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.omtm.2022.07.014","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030131170","display_name":"Kimberly Viker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly B. Viker","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079277994","display_name":"Michael B. Steele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Steele","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028587627","display_name":"Ianko D. Iankov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ianko D. Iankov","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071259414","display_name":"Susanna C. Concilio","orcid":"https://orcid.org/0000-0001-6950-2146","observed_orcids":["https://orcid.org/0000-0001-6950-2146"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanna C. Concilio","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023557037","display_name":"Arun Ammayappan","orcid":"https://orcid.org/0000-0002-0453-7310","observed_orcids":["https://orcid.org/0000-0002-0453-7310"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arun Ammayappan","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011929463","display_name":"Brad N. Bolon","orcid":"https://orcid.org/0000-0002-6065-1492","observed_orcids":["https://orcid.org/0000-0002-6065-1492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brad Bolon","raw_affiliation_strings":["GEMpath, Inc., Longmont, CO 80501, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GEMpath, Inc., Longmont, CO 80501, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967783","display_name":"Nathan J. Jenks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan J. Jenks","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008665323","display_name":"Matthew Philip Goetz","orcid":"https://orcid.org/0000-0002-4383-270X","observed_orcids":["https://orcid.org/0000-0002-4383-270X","https://orcid.org/0000-0003-3588-024X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew P. Goetz","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035466234","display_name":"Eleni Panagioti","orcid":"https://orcid.org/0000-0002-7574-1378","observed_orcids":["https://orcid.org/0000-0002-7574-1378"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eleni Panagioti","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058119708","display_name":"Mark J. Federspiel","orcid":"https://orcid.org/0000-0002-3713-186X","observed_orcids":["https://orcid.org/0000-0002-3713-186X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Federspiel","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109934123","display_name":"MC Liu","orcid":"https://orcid.org/0000-0002-8206-5232","observed_orcids":["https://orcid.org/0000-0002-8206-5232"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Minetta C. Liu","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110843369","display_name":"Kah Whye Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kah Whye Peng","raw_affiliation_strings":["Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017494786","display_name":"Evanthia Galanis","orcid":"https://orcid.org/0000-0001-8014-786X","observed_orcids":["https://orcid.org/0000-0001-8014-786X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Evanthia Galanis","raw_affiliation_strings":["Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA"],"raw_orcid":"https://orcid.org/0000-0001-8014-786X","affiliations":[{"raw_affiliation_string":"Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017494786"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":2.5533,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.90402477,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"26","issue":null,"first_page":"532","last_page":"546"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-measles-virus","display_name":"oncolytic measles virus","score":0.8709999918937683},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8209999799728394},{"id":"https://openalex.org/keywords/oncolytic-virotherapy","display_name":"oncolytic virotherapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.6990000009536743},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.5690000057220459},{"id":"https://openalex.org/keywords/immunostimulation","display_name":"immunostimulation","score":0.6340000033378601},{"id":"https://openalex.org/keywords/breast-cancer-xenografts","display_name":"breast cancer xenografts","score":0.7329999804496765},{"id":"https://openalex.org/keywords/intratumoral-administration","display_name":"intratumoral administration","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.7819434404373169},{"id":"https://openalex.org/C2778199166","wikidata":"https://www.wikidata.org/wiki/Q573943","display_name":"Measles virus","level":4,"score":0.7804852724075317},{"id":"https://openalex.org/C107513589","wikidata":"https://www.wikidata.org/wiki/Q5242962","display_name":"Nap","level":2,"score":0.7028838992118835},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6554359197616577},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.5138424038887024},{"id":"https://openalex.org/C2778022156","wikidata":"https://www.wikidata.org/wiki/Q576145","display_name":"Strain (injury)","level":2,"score":0.5043662786483765},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.47296470403671265},{"id":"https://openalex.org/C2776438120","wikidata":"https://www.wikidata.org/wiki/Q79793","display_name":"Measles","level":3,"score":0.4531278610229492},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4060344099998474},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.36539387702941895},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14531955122947693},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.14390909671783447},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07403257489204407},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0},{"id":"https://openalex.org/C105702510","wikidata":"https://www.wikidata.org/wiki/Q514","display_name":"Anatomy","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.omtm.2022.07.014","doi":"https://doi.org/10.1016/j.omtm.2022.07.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2022.07.014","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Methods & Clinical Development","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9437807","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9437807","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther Methods Clin Dev","raw_type":"Text"},{"id":"pmid:36092362","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36092362","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy. Methods & clinical development","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:57a8d49639d54665a6d7814a47ceb75e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/57a8d49639d54665a6d7814a47ceb75e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Therapy: Methods & Clinical Development, Vol 26, Iss , Pp 532-546 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.omtm.2022.07.014","doi":"https://doi.org/10.1016/j.omtm.2022.07.014","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2022.07.014","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Methods & Clinical Development","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6234919981","display_name":"Optimizing Delivery of Oncolytic Measles Virus Strains with Cell Carriers","funder_award_id":"R01CA200507","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000866180","display_name":"Mayo Clinic Comprehensive Cancer Center Support Grant","funder_award_id":"P30CA015083","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000912503","display_name":"Mayo Clinic Breast Cancer SPORE","funder_award_id":"P50CA116201","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W106272877","https://openalex.org/W1503535277","https://openalex.org/W1581511516","https://openalex.org/W1787451882","https://openalex.org/W1848677555","https://openalex.org/W1989215766","https://openalex.org/W1993935564","https://openalex.org/W1996434139","https://openalex.org/W1999009503","https://openalex.org/W2005162396","https://openalex.org/W2006133563","https://openalex.org/W2006161766","https://openalex.org/W2011021306","https://openalex.org/W2012836568","https://openalex.org/W2029647918","https://openalex.org/W2032396826","https://openalex.org/W2041875768","https://openalex.org/W2043083527","https://openalex.org/W2053449086","https://openalex.org/W2054319738","https://openalex.org/W2056289798","https://openalex.org/W2063931232","https://openalex.org/W2074781545","https://openalex.org/W2083613729","https://openalex.org/W2084461655","https://openalex.org/W2093780636","https://openalex.org/W2095615635","https://openalex.org/W2096574915","https://openalex.org/W2097011626","https://openalex.org/W2102883003","https://openalex.org/W2105778444","https://openalex.org/W2109274792","https://openalex.org/W2118541088","https://openalex.org/W2120633194","https://openalex.org/W2131816598","https://openalex.org/W2135002443","https://openalex.org/W2158770026","https://openalex.org/W2165320653","https://openalex.org/W2177826333","https://openalex.org/W2195308822","https://openalex.org/W2515581978","https://openalex.org/W2521683773","https://openalex.org/W2521998735","https://openalex.org/W2548144092","https://openalex.org/W2590596176","https://openalex.org/W2750781282","https://openalex.org/W2760883434","https://openalex.org/W2763265527","https://openalex.org/W2889646458","https://openalex.org/W2914643394","https://openalex.org/W2942554478","https://openalex.org/W2969017474","https://openalex.org/W3080269137","https://openalex.org/W3149716062","https://openalex.org/W3173215659","https://openalex.org/W4230151434","https://openalex.org/W6604366196","https://openalex.org/W6727001982"],"related_works":["https://openalex.org/W1994780813","https://openalex.org/W64739767","https://openalex.org/W2007129787","https://openalex.org/W1986482300","https://openalex.org/W4414421604","https://openalex.org/W2326188964","https://openalex.org/W4297025583","https://openalex.org/W2534125264","https://openalex.org/W2093783193","https://openalex.org/W2043083527"],"abstract_inverted_index":{"Despite":[0],"recent":[1],"therapeutic":[2],"advances,":[3],"metastatic":[4],"breast":[5,90],"cancer":[6,91],"(MBC)":[7],"remains":[8],"incurable.":[9],"Engineered":[10],"measles":[11],"virus":[12],"(MV)":[13],"constructs":[14],"based":[15],"on":[16],"the":[17,40,57,73,108,126,129,156,185],"attenuated":[18],"MV":[19,69],"Edmonston":[20],"vaccine":[21],"platform":[22],"have":[23],"demonstrated":[24],"significant":[25,174],"oncolytic":[26,190],"activity":[27,87],"against":[28],"solid":[29],"tumors.":[30],"The":[31,114,194],"Helicobacter":[32],"pylori":[33],"neutrophil-activating":[34],"protein":[35],"(NAP)":[36],"is":[37],"responsible":[38],"for":[39,189],"robust":[41],"inflammatory":[42],"reaction":[43],"in":[44,88,147,200],"gastroduodenal":[45],"mucosa":[46],"during":[47],"bacterial":[48],"infection.":[49],"NAP":[50,77],"attracts":[51],"and":[52,79,85,110,124,162],"activates":[53],"immune":[54],"cells":[55],"at":[56],"site":[58],"of":[59,63,76,112,128,133,142,145,168,187,192,198],"infection,":[60],"inducing":[61],"expression":[62],"pro-inflammatory":[64],"mediators.":[65],"We":[66],"engineered":[67],"an":[68],"strain":[70],"to":[71,106,118,136,155],"express":[72],"secretory":[74],"form":[75],"(MV-s-NAP)":[78],"showed":[80],"that":[81],"it":[82],"exhibits":[83],"anti-tumor":[84],"immunostimulatory":[86],"human":[89],"xenograft":[92],"models.":[93],"In":[94],"this":[95],"study,":[96],"we":[97],"utilized":[98],"a":[99,137],"measles-infection-permissive":[100],"mouse":[101],"model":[102],"(transgenic":[103],"IFNAR":[104],"KO-CD46Ge)":[105],"evaluate":[107],"biodistribution":[109],"safety":[111,127,186],"MV-s-NAP.":[113],"primary":[115],"objective":[116],"was":[117,180,206],"identify":[119],"potential":[120],"toxic":[121],"side":[122],"effects":[123],"confirm":[125],"proposed":[130],"clinical":[131,140,157,196],"doses":[132],"MV-s-NAP":[134,146,169,188,199],"prior":[135],"phase":[138],"I":[139],"trial":[141,158,197],"intratumoral":[143,159],"administration":[144,160],"patients":[148,201],"with":[149,202],"MBC.":[150,193],"Both":[151],"subcutaneous":[152],"delivery":[153,167],"(corresponding":[154],"route)":[161],"intravenous":[163],"(worst":[164],"case":[165],"scenario)":[166],"were":[170],"well":[171],"tolerated:":[172],"no":[173],"clinical,":[175],"laboratory":[176],"or":[177],"histologic":[178],"toxicity":[179],"observed.":[181],"This":[182],"outcome":[183],"supports":[184],"virotherapy":[191],"first-in-human":[195],"MBC":[203],"(ClinicalTrials.gov:":[204],"NCT04521764)":[205],"subsequently":[207],"activated.":[208]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-08-01T00:00:00"}